GlassScriptPhysician profile
Rafic H Zaitoun
NPI 1588651228
$1,150.46
in general payments reported to CMS, 2019-2025
18 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $74.59 · 2021: $88.72 · 2022: $186 · 2023: $191 · 2024: $187 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $226.32 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $179.43 | 2019-2024 | |
| Pfizer INC. | $157.70 | 2020-2025 | |
| Akcea Therapeutics, INC. | $125.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.73 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $62.85 | 2024-2025 | |
| Philips North America LLC | $53.76 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $38.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $36.25 | 2020-2021 | |
| Cordis US Corp. | $30.45 | 2025 | Mynx Control Venous |
| Shockwave Medical, INC | $25.65 | 2022 | |
| Medtronic Vascular, INC. | $21.05 | 2020 | |
| Bridgebio Pharma, INC. | $18.65 | 2025 | Attruby |
| Angiodynamics, INC. | $18.37 | 2023 | Auryon Laser System 100-120 Vac |
| Stryker Corporation | $15.35 | 2024 | N/A |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14.76 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $13.75 | 2024 | Farxiga |
| Bard Peripheral Vascular, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafic Zaitoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.